You searched for prescription-drugs | Page 40 of 177

New Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare

Jul 6, 2023

Policy Watch

The Food and Drug Administration granted full approval to Leqembi, a new Alzheimer's drug, on July 6, 2023. This updated policy watch focuses on the implications of Medicare coverage of the drug for program spending as well as equity and affordability issues for beneficiaries, and the potential for the Inflation Reduction Act to address the spending impacts. It also covers additional details from the Centers for Medicare and Medicaid Services about patient registries.

States are Shifting How They Cover Prescription Drugs in Response to COVID-19

Apr 30, 2020

Policy Watch

Medicaid beneficiaries, particularly those with chronic conditions, will need access to medications even during social distancing and their ability to meet with providers to obtain refills may be hindered. States are updating policies to allow beneficiaries to access medications during this public health emergency.

KFF Health Tracking Poll – March 2022: Economic Concerns and Health Policy, The ACA, and Views of Long-term Care Facilities

Mar 31, 2022

Feature

This poll finds the public's health care priorities for Congress focus on reducing out-of-pocket costs, and concerns over inflation and the economy are top of mind as voters begin to think about the November midterm elections. The poll also examines views of the ACA and nursing homes.

Recent Developments and Key Issues to Watch with Medicaid Section 1115 Waivers

Sep 28, 2022

Policy Watch

This policy watch describes the current landscape of Section 1115 waivers and highlights key issues to watch: the outcome of litigation related to Georgia’s waiver, as well as the Biden Administration’s decisions on pending requests from Tennessee and other states.

Medicare Part B Drugs: Cost Implications for Beneficiaries in Traditional Medicare and Medicare Advantage

Mar 15, 2022

Issue Brief

In the face of rising prescription drug costs, a large majority of the public supports federal efforts to lower drug spending. Policymakers are considering several proposals that would lower prescription drug costs. To better understand the potential out-of-pocket cost exposure that Medicare beneficiaries may face for Part B drugs, which are typically administered by physicians and other health care providers, we analyzed cost-sharing liability for these drugs in traditional Medicare and cost-sharing requirements in Medicare…

Medicaid Coverage of Behavioral Health Services in 2022: Findings from a Survey of State Medicaid Programs

Mar 17, 2023

Issue Brief

To better understand the variation in access to behavioral health services for adults in Medicaid, KFF surveyed state Medicaid officials about behavioral health benefits covered for adult enrollees in their fee-for-service programs.

Fate of Medicaid Expansion and Filling the Coverage Gap May Once Again Depend on the Outcome of State Elections

Aug 17, 2022

Policy Watch

This post examines the potential for this year's midterm elections to decide the fate of Medicaid expansion, with gubernatorial races in 10 of the 12 states that have not expanded, including Georgia, Kansas and Wisconsin, where the gubernatorial race is considered a toss-up. South Dakota voters also will decide a Medicaid expansion ballot initiative.

2024 Employer Health Benefits Chart Pack

Oct 9, 2024

Feature

This slideshow captures key data from the 2024 KFF Employer Health Benefits Survey survey, providing a detailed look at trends in employer-sponsored health coverage, including premiums, employee contributions, cost-sharing, abortion coverage, offer rates, wellness programs, and other employer practices.

Selected Out-of-Pocket Costs as a Share of the Average Social Security Benefit

Apr 29, 2022

Feature

Medicare premiums and cost sharing will account for an increasing share of Social Security benefits in the future, Medicare Trustees project.

Strategies to Manage Unwinding Uncertainty for Medicaid Managed Care Plans: Medical Loss Ratios, Risk Corridors, and Rate Amendments

Apr 10, 2023

Issue Brief

This brief provides a high-level snapshot of states with minimum medical loss ratio (MLR) and remittance requirements and risk corridors in place as of July 1, 2022 that may provide financial protection and limits on financial risk for states and plans as the unwinding unfolds.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

Search

Filter